Both extracellular vesicles from helicobacter pylori-infected cells and helicobacter pylori outer membrane vesicles are involved in gastric/extragastric diseases

• Published in: European journal of medical research Vol. 28; no. 1; pp. 1 - 484
• Main Authors: Wang, Chengyao, Li, Wenkun, Shao, Linlin, Zhou, Anni, Zhao, Mengran, Li, Peng, Zhang, Zheng, Wu, Jing
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 06-11-2023; BioMed Central; BMC
• Subjects: Alzheimer's disease; Antigens; Apoptosis; Bacteria; Bacterial infections; Chronic obstructive pulmonary disease; Communicable diseases; Cytokines; Development and progression; Endothelium; Enzymes; Extra-gastrointestinal disease; Extracellular vesicles; Gastric cancer; Gene expression; Health aspects; Helicobacter infections; Helicobacter pylori; Infections; Lipids; MicroRNAs; Outer membrane vesicles; Pathogens; Proteins; Review; Stomach; Stomach cancer
• ISSN: 2047-783X; 0949-2321; 2047-783X
• DOI: 10.1186/s40001-023-01458-z

Bacterial-derived extracellular vesicles (EVs) have emerged as crucial mediators in the cross-talk between hosts and pathogens, playing a significant role in infectious diseases and cancers. Among these pathogens, Helicobacter pylori (H. pylori) is a particularly important bacterium implicated in various gastrointestinal disorders, gastric cancers, and systemic illnesses. H. pylori achieves these effects by stimulating host cells to secrete EVs and generating internal outer membrane vesicles (OMVs). The EVs derived from H. pylori-infected host cells modulate inflammatory signaling pathways, thereby affecting cell proliferation, apoptosis, cytokine release, immune cell modification, and endothelial dysfunction, as well as disrupting cellular junctional structures and inducing cytoskeletal reorganization. In addition, OMVs isolated from H. pylori play a pivotal role in shaping subsequent immunopathological responses. These vesicles incite both inflammatory and immunosuppressive reactions within the host environment, facilitating pathogen evasion of host defenses and invasion of host cells. Despite this growing understanding, research involving H. pylori-derived EVs remains in its early stages across different domains. In this comprehensive review, we present recent advancements elucidating the contributions of EV components, such as non-coding RNAs (ncRNAs) and proteins, to the pathogenesis of gastric and extragastric diseases. Furthermore, we highlight their potential utility as biomarkers, therapeutic targets, and vehicles for targeted delivery.